open access to scientific and medical research

Back to Journals » ClinicoEconomics and Outcomes Research » Volume 7

Original Research

Noteworthy comment: In health technology assessment (HTA) agencies where cost-effectiveness plays a role in decision-making, an incremental cost-effectiveness ratio (ICER) threshold is often used to inform reimbursement decisions. Acceptance of submissions with higher-than-threshold ICERs varied by HTA agency and was not significantly influenced by disease category. Such submissions must be accompanied by robust, concrete, and transparent evidence in order to achieve patient access.

Highly-accessed

Acceptance of health technology assessment submissions with incremental cost-effectiveness ratios above the cost-effectiveness threshold

Total article views		HTML views	PDF downloads	Totals
19,937	Dovepress*	17,113+	1,756	18,869
	PubMed Central*	2,824	747	3,571
	Totals	19,937	2,503	22,440
*Since 31 August 2015 +Since July 2016

Total mentioned	Facebook	Delicious	Reddit	Twitter	Others
2	0	0	0	1	1

View citations on PubMed Central and Google Scholar